Related Experiment Video

Updated: May 10, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

Targeting drug delivery systems for circumventing multidrug resistance of cancers

Rui-Jun Ju1, Li-Min Mu, Wan-Liang Lu

  • 1School of Pharmaceutical Sciences, Peking University, Beijing, China.

Therapeutic Delivery
|June 7, 2013
PubMed

Insights

New liposome and nanomicelle delivery systems overcome multidrug resistance in cancer. These nanoscale formulations enhance chemotherapy efficacy in resistant cancer and cancer stem cells, showing promise for improved treatment outcomes.

Area of Science:

  • Oncology
  • Nanotechnology
  • Drug Delivery Systems

Background:

  • Multidrug resistance (MDR) significantly hinders effective cancer chemotherapy.
  • Developing novel strategies is crucial to overcome MDR and improve patient outcomes.

Purpose of the Study:

  • To develop advanced liposome and nanomicelle delivery systems to combat multidrug resistance in cancer.
  • To investigate the efficacy of these nanoscale formulations against various aspects of cancer, including resistant cell membranes, cancer stem cells, mitochondria, apoptosis, and tumor heterogeneity.

Main Methods:

  • Investigated resistant cancer cell membranes, cancer stem cells, mitochondria, apoptosis genes, vasculogenic mimicry, and cancer cell heterogeneity.
  • Evaluated the performance of liposome and nanomicelle systems in cancer cells, cancer spheroids, and preclinical cancer animal models.

Main Results:

  • Nanoscale formulations, including liposomes and nanomicelles, demonstrated significant potential in overcoming multidrug resistance.
  • Enhanced chemotherapy efficacy was observed in vitro and in vivo, particularly in resistant cancer cells and cancer stem cells.

Conclusions:

  • Liposome and nanomicelle delivery systems represent a promising approach to overcoming multidrug resistance in cancer therapy.
  • These advanced formulations offer enhanced efficacy against challenging cancer types, including those with stem cell characteristics.

More Related Videos

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...